Loading…
Transcript

What

We

Offer?

At a glance

Established in 2019, with a vision to create a global self-learning AI driven medical database, that is going change the way future medical practitioners will access data, learn from it, manage it and update in real time.

At a glance

The medical arena is changing

The global medical arena is changing

In the past decade more and more research has been made in the field of natural substances by premier research institutes and clinics worldwide (i.e. medical cannabis, medicinal mushrooms, psychotropic plants). Currently the information keeps piling up rapidly and the medical community has no efficient to organise it, nor use it effectively in both in community and private medical settings.

Furthermore, physicians who wish to use it for the benefits of their clients, are facing a huge knowledge gap, mainly due to the fact that these bodies of massive information simply do not exist in any medical school curriculums. In spite of that, we can see that many medical institutes and clinics are trying to implement this valuable knowledge into their practice, however with limited access to information and lack of education.

OUR REVOLUTION

Our Revolutio

The professional use of natural substances is on the rise worldwide, this is a revolution and the demand for precise and updated information is high. Now more than ever, researchers need a global database platform that will manage all existing data on these subjects - that is why we create Curro.

WHAT WE OFFER

Curro will immensely benefit patients care by giving physicians a revolutionary tool, both clinical and educative. We also expect it to become a major player in the arena of research and clinical data management by enabling the research community a unique way of access to the global information highway.

We teamed up with the best knowledgeable medical professionals from Israel and US, practitioners with massive clinical experience of thousands of patients over several decades.

Our competitive software tech team are focusing on creating an innovative professional global data platform to both fill the existing knowledge gap, while creating a whole new exciting market of data management and data/product commerce.

OUR OFFICES

London

San Francisco

Brussels

New York

Beijing

Houston

Hong Kong

Our Mission

Our Team

The

platform

We have a mission to help people around the world in finding the best solutions based on natural & herbal substances and products.

Currently around the world we can see a big shift of medical doctors and scientists toward investigating and using raw materials from nature in both research various and clinical settings.

We see a huge knowledge gap in the medical/clinical and research industry, which we aim to solve by our progressive data platform.

Initial data will be provided by our world-wide medical team based on the actual therapeutics used.

In later stage, many doctors which share the same vision will add more clinical data about the actual therapeutics being currently used globally.

The Platform

The Platform

Doctors will use this platform as a real-time up-to-date tool for helping their patients while constantly adding a “peer to peer” knowledge while using the platform.

Furthermore, our contributing experts in the platform will be able to provide an on-line consulting service to any person who wishes to have more information about the actual treatment currently used for a given indication.

Accessibility and efficiency

Accessible and effective knowledge base

Researchers and research institutes will be able to access the platform to be used as a clinical research tool and a knowledge base, while adding to the platform their own gained info, making it constantly updated.

Patients will be able to explore and learn more about potential known treatments which used to improve their wellbeing.

Additionally, patients and doctors will be able to be routed to a marketplace where they can order or prescribe easily the desired treatment/product from a verity of qualified vendors/pharmacies.

On the wholesale arena, we will offer a B2B platform that will offer dealers to buy and sell on a large scale, both industry raw materials and complete products.

Sales

and revenues

We aim to generate revenue from the below vectors:

1) Revenue share from each product sale through the marketplace.

2) Fee for consultancy service being ordered from doctors.

3) Premium subscription from patients & families for advanced professional data.

4) Premium subscription from doctors and institutes( in later stage).

5) B2B data sale mainly for research, statistics and marketing.

6) B2B marketplace wholesale online deals.

7) Open global search engine portal with online ads.

Medical advisory board

Medical advisory board

Dr. Rachel Knox - Dr. Knox uses her expertise, experience and knowledge of cannabis therapeutics to help cure and relieve symptoms of chronic disease that traditional medicine has failed to conquer. Dr. Knox is certified by the American Academy of Cannabinoid Medicine as a Cannabinoid Medicine Specialist. Dr. Janice is a much sought-after speaker for cannabis therapeutics nationally and abroad. Dr. Knox is a co-founder of The American Cannabinoid Clinics and ADVENT Academy.

Dr. Knox also serves as the Oregon representative to the DFCR.

Mario Hilou – Mr. Hilou was a head nurse for 14 years in a cannabis company. Currently the owner of a cannabis patient counseling center.

Dr. David Casarett – Dr. Casarett is a palliative care physician and health services researcher whose work focuses on improving systems of care for people with serious, life-threatening illnesses. He is a Professor of Medicine at the Duke University School of Medicine, and the Chief of Palliative Care in Duke Health. Dr. Casarett is the author of more than 100 articles in journals including JAMA and The New England Journal of Medicine, and his writing has appeared in print and online in Salon, Esquire, Discover, Newsweek, the New York Times, and Wired. He is a recipient of the Presidential Early Career Award for Scientists and Engineers, the highest honor given by the US government to researchers in the early stages of their careers.

Dr. Casarett is also the author of three non-fiction books, the most recent of which was Stoned: A Doctor’s Case for Medical Marijuana.

Dr. Natalya Kogen –Dr. Kogen is Doctoral student in Professor Rafael Meshulam's laboratory. In her recent study she has found that a derivative of one of the cannabis plant (cannabis) substances is effective in stopping cancerous tumors. At this stage, experiments were carried out on cells and animals.

Prof. Itzhak Shapira- Prof. Shapira is Deputy Director General of the Tel Aviv Sourasky Medical Center ; Director, Rehabilitation Hospital; Associated Dean.

Dr. Silviu Brill –Dr. Brill is director of the Tel Aviv Sourasky Medical Center Pain Institute and one of the veterans in the treatment of cannabis in Israel. Serves as president of the Israeli Association of Pain, and formerly the chair of the Pain Circle on behalf of the Association of Anesthesiologists

In the academy, Dr. Brill lectures at the Ben Gurion University Faculty of Medicine.

In addition, he has published some 30 professional writings, authored the book "Pain, Diagnosis to Relief" on Pain and attended hundreds of national and international conferences in the field.

Dr. Brill specializes in the treatment of neuropathic pain, back pain, implantation systems for spinal cord stimulation, invasive methods for the treatment of chronic pain, and the treatment of pain from cancer.

Head of Cannabis and Medicines Study Center Related to its Mechanism of Action.

Prof. Zvi Bentwich-Prof. Bentwich is a physician, clinical immunologist and world-renowned expert on AIDS research, with vast clinical, educational and biomedical research experience. In 1982 he became the first physician to deal with AIDS in Israel and founded the first and largest AIDS centre in the country. Professor Bentwich is Professor Emeritus of Medicine of the Hebrew University Hadassah Medical School and currently, Professor of Microbiology Immunology and Genetics, and head of the Center for Emerging Tropical Diseases & AIDS, at the Ben Gurion University. He is the author of over 270 peer-reviewed scientific publications. Between 2002-2009, Dr. Bentwich was Chief Scientist of Rosetta Genomics Inc, (NASDAQ ROSG) and since 2012 he is the Scientific Director of the Ein Gedi - Dead Sea Arava Science Center where he is deeply involved in studies of medicinal plants and the skin microbiome.

In 2015 he became a Chief Scientist of a big cannabis company, the largest medical cannabis company in Israel, where he leads several clinical trials for cannabis. Professor Bentwich has been a board member (2002-2014) and chairman (2010-2012) of Physicians for Human Rights, Israel. Among other awards, in 2010, he received a lifetime award from the Israeli Knesset for his contributions to Israel Medicine and Medical Sciences

The Platform

Doctors will use this platform as a real-time up-to-date tool for helping their patients while constantly adding a “peer to peer” knowledge while using the platform.

Furthermore, our contributing experts in the platform will be able to provide an on-line consulting service to any person who wishes to have more information about the actual treatment currently used for a given indication.

The Platform

Doctors will use this platform as a real-time up-to-date tool for helping their patients while constantly adding a “peer to peer” knowledge while using the platform.

Furthermore, our contributing experts in the platform will be able to provide an on-line consulting service to any person who wishes to have more information about the actual treatment currently used for a given indication.

The Platform

Doctors will use this platform as a real-time up-to-date tool for helping their patients while constantly adding a “peer to peer” knowledge while using the platform.

Furthermore, our contributing experts in the platform will be able to provide an on-line consulting service to any person who wishes to have more information about the actual treatment currently used for a given indication.

The Platform

Doctors will use this platform as a real-time up-to-date tool for helping their patients while constantly adding a “peer to peer” knowledge while using the platform.

Furthermore, our contributing experts in the platform will be able to provide an on-line consulting service to any person who wishes to have more information about the actual treatment currently used for a given indication.

The Platform

Doctors will use this platform as a real-time up-to-date tool for helping their patients while constantly adding a “peer to peer” knowledge while using the platform.

Furthermore, our contributing experts in the platform will be able to provide an on-line consulting service to any person who wishes to have more information about the actual treatment currently used for a given indication.

The Platform

Doctors will use this platform as a real-time up-to-date tool for helping their patients while constantly adding a “peer to peer” knowledge while using the platform.

Furthermore, our contributing experts in the platform will be able to provide an on-line consulting service to any person who wishes to have more information about the actual treatment currently used for a given indication.

The Platform

Doctors will use this platform as a real-time up-to-date tool for helping their patients while constantly adding a “peer to peer” knowledge while using the platform.

Furthermore, our contributing experts in the platform will be able to provide an on-line consulting service to any person who wishes to have more information about the actual treatment currently used for a given indication.

The Platform

Doctors will use this platform as a real-time up-to-date tool for helping their patients while constantly adding a “peer to peer” knowledge while using the platform.

Furthermore, our contributing experts in the platform will be able to provide an on-line consulting service to any person who wishes to have more information about the actual treatment currently used for a given indication.

The Platform

Doctors will use this platform as a real-time up-to-date tool for helping their patients while constantly adding a “peer to peer” knowledge while using the platform.

Furthermore, our contributing experts in the platform will be able to provide an on-line consulting service to any person who wishes to have more information about the actual treatment currently used for a given indication.

The Platform

Doctors will use this platform as a real-time up-to-date tool for helping their patients while constantly adding a “peer to peer” knowledge while using the platform.

Furthermore, our contributing experts in the platform will be able to provide an on-line consulting service to any person who wishes to have more information about the actual treatment currently used for a given indication.

Accessible and effective knowledge base

Researchers and research institutes will be able to access the platform to be used as a clinical research tool and a knowledge base, while adding to the platform their own gained info, making it constantly updated.

Patients will be able to explore and learn more about potential known treatments which used to improve their wellbeing.

Additionally, patients and doctors will be able to be routed to a marketplace where they can order or prescribe easily the desired treatment/product from a verity of qualified vendors/pharmacies.

On the wholesale arena, we will offer a B2B platform that will offer dealers to buy and sell on a large scale, both industry raw materials and complete products.

Accessible and effective knowledge base

Researchers and research institutes will be able to access the platform to be used as a clinical research tool and a knowledge base, while adding to the platform their own gained info, making it constantly updated.

Patients will be able to explore and learn more about potential known treatments which used to improve their wellbeing.

Additionally, patients and doctors will be able to be routed to a marketplace where they can order or prescribe easily the desired treatment/product from a verity of qualified vendors/pharmacies.

On the wholesale arena, we will offer a B2B platform that will offer dealers to buy and sell on a large scale, both industry raw materials and complete products.

Accessible and effective knowledge base

Researchers and research institutes will be able to access the platform to be used as a clinical research tool and a knowledge base, while adding to the platform their own gained info, making it constantly updated.

Patients will be able to explore and learn more about potential known treatments which used to improve their wellbeing.

Additionally, patients and doctors will be able to be routed to a marketplace where they can order or prescribe easily the desired treatment/product from a verity of qualified vendors/pharmacies.

On the wholesale arena, we will offer a B2B platform that will offer dealers to buy and sell on a large scale, both industry raw materials and complete products.

Accessible and effective knowledge base

Researchers and research institutes will be able to access the platform to be used as a clinical research tool and a knowledge base, while adding to the platform their own gained info, making it constantly updated.

Patients will be able to explore and learn more about potential known treatments which used to improve their wellbeing.

Additionally, patients and doctors will be able to be routed to a marketplace where they can order or prescribe easily the desired treatment/product from a verity of qualified vendors/pharmacies.

On the wholesale arena, we will offer a B2B platform that will offer dealers to buy and sell on a large scale, both industry raw materials and complete products.

Accessible and effective knowledge base

Researchers and research institutes will be able to access the platform to be used as a clinical research tool and a knowledge base, while adding to the platform their own gained info, making it constantly updated.

Patients will be able to explore and learn more about potential known treatments which used to improve their wellbeing.

Additionally, patients and doctors will be able to be routed to a marketplace where they can order or prescribe easily the desired treatment/product from a verity of qualified vendors/pharmacies.

On the wholesale arena, we will offer a B2B platform that will offer dealers to buy and sell on a large scale, both industry raw materials and complete products.

Accessible and effective knowledge base

Researchers and research institutes will be able to access the platform to be used as a clinical research tool and a knowledge base, while adding to the platform their own gained info, making it constantly updated.

Patients will be able to explore and learn more about potential known treatments which used to improve their wellbeing.

Additionally, patients and doctors will be able to be routed to a marketplace where they can order or prescribe easily the desired treatment/product from a verity of qualified vendors/pharmacies.

On the wholesale arena, we will offer a B2B platform that will offer dealers to buy and sell on a large scale, both industry raw materials and complete products.

Accessible and effective knowledge base

Researchers and research institutes will be able to access the platform to be used as a clinical research tool and a knowledge base, while adding to the platform their own gained info, making it constantly updated.

Patients will be able to explore and learn more about potential known treatments which used to improve their wellbeing.

Additionally, patients and doctors will be able to be routed to a marketplace where they can order or prescribe easily the desired treatment/product from a verity of qualified vendors/pharmacies.

On the wholesale arena, we will offer a B2B platform that will offer dealers to buy and sell on a large scale, both industry raw materials and complete products.

Accessible and effective knowledge base

Researchers and research institutes will be able to access the platform to be used as a clinical research tool and a knowledge base, while adding to the platform their own gained info, making it constantly updated.

Patients will be able to explore and learn more about potential known treatments which used to improve their wellbeing.

Additionally, patients and doctors will be able to be routed to a marketplace where they can order or prescribe easily the desired treatment/product from a verity of qualified vendors/pharmacies.

On the wholesale arena, we will offer a B2B platform that will offer dealers to buy and sell on a large scale, both industry raw materials and complete products.

Accessible and effective knowledge base

Researchers and research institutes will be able to access the platform to be used as a clinical research tool and a knowledge base, while adding to the platform their own gained info, making it constantly updated.

Patients will be able to explore and learn more about potential known treatments which used to improve their wellbeing.

Additionally, patients and doctors will be able to be routed to a marketplace where they can order or prescribe easily the desired treatment/product from a verity of qualified vendors/pharmacies.

On the wholesale arena, we will offer a B2B platform that will offer dealers to buy and sell on a large scale, both industry raw materials and complete products.

Accessible and effective knowledge base

Researchers and research institutes will be able to access the platform to be used as a clinical research tool and a knowledge base, while adding to the platform their own gained info, making it constantly updated.

Patients will be able to explore and learn more about potential known treatments which used to improve their wellbeing.

Additionally, patients and doctors will be able to be routed to a marketplace where they can order or prescribe easily the desired treatment/product from a verity of qualified vendors/pharmacies.

On the wholesale arena, we will offer a B2B platform that will offer dealers to buy and sell on a large scale, both industry raw materials and complete products.